CGTLive®’s Weekly Rewind – May 3, 2024


Review top news and interview highlights from the week ending May 3, 2024.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind

Welcome to CGTLive®’s Weekly Rewind! We’ve compiled 5 highlights from this week’s coverage of advances in gene and cell therapies, including FDA actions, notable research, and interviews with experts across the field.

1. TMZ γδ T-Cell Regimen May Have Potential in Treating Glioblastoma

A phase 1 trial evaluating INB-200 has shown a PFS benefit in treated participants.

2. Deepak L. Bhatt, MD, MPH, MBA, on Adopting Novel Therapies into Cardiovascular Medicine

The director of the Mount Sinai Fuster Heart Hospital discussed trends in research and challenges with adopting new therapies.

3. Parkinson Gene Therapy Shows Stability, Some Improvements in On/Off Time Disease Measures

Based off these data, the phase 2 Regenerate PD trial of AB-1005 will begin enrolling later this year.

4. Amit Soni, MD, on Challenges to the Uptake of Gene Therapy for Hemophilia

The medical director of the Center for Inherited Blood Disorders discussed barriers to the widespread adoption of val-rox by the hemophilia A community.

5. Ferring Testing Bladder Cancer Gene Therapy Adstiladrin’s Mettle in Real-World Setting With ABLE-41 Observational Study

In anticipation of Bladder Cancer Awareness Month, CGTLive® has decided to take a closer look at this noninterventional real-world study.

Related Videos
Evan Weber, PhD, an assistant professor of pediatrics at Children's Hospital of Philadelphia
Shankar Ramaswamy, MD, the cofounder, chairman, and CEO of Kriya Therapeutics
Kevin Campbell, PhD, a Howard Hughes Investigator at the University of Iowa
Debora Mazzetti, MS, on Multitargeting MicroRNA in Glioblastoma
Francesca Del Bufalo, MD, PhD, a medical doctor and scientist at Bambino Gesù Chidren’s Hospital
Travis Drow, BS, a research scientist at Seattle Children's Research Institute
Carlos Ramos, MD, on Alternatives to T-Cell Therapy
Omer A. Abdul Hamid, MD, on Sharing Expertise With Gene Therapy Logistics
© 2024 MJH Life Sciences

All rights reserved.